Clinical trial
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft…
NCT00041249 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00041249 |
|---|---|
| Title | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma |
| Official title | Efficacy And Safety Study Of Brostallicin In Patients With Locally Advanced Or Metastatic Soft Tissue Sarcoma Failing One Prior Chemotherapy Treatment |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Stromal Tumor, Sarcoma |
| Intervention type | Drug |
| Interventions | brostallicin |
| Enrollment | 64 |
| Start date | May 1, 2002 |
| Primary completion | Jan 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 18, 2012 |
| Countries | Belgium, France, Germany, Netherlands, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: